位置:首页 > 蛋白库 > PIOX_ORYSJ
PIOX_ORYSJ
ID   PIOX_ORYSJ              Reviewed;         618 AA.
AC   Q2QRV3; Q0INH8; Q9M5J1;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Alpha-dioxygenase PIOX {ECO:0000305};
DE            EC=1.13.11.92 {ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
DE   AltName: Full=Pathogen-induced oxygenase {ECO:0000303|PubMed:21790181};
GN   Name=PIOX {ECO:0000303|PubMed:21790181};
GN   OrderedLocusNames=Os12g0448900 {ECO:0000312|EMBL:BAT17016.1},
GN   LOC_Os12g26290 {ECO:0000312|EMBL:ABA98060.2};
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Matsui K., Koeduka T., Akakabe Y., Kajiwara T.;
RT   "Fatty acid alpha-oxidases in rice plants.";
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16188032; DOI=10.1186/1741-7007-3-20;
RG   The rice chromosomes 11 and 12 sequencing consortia;
RT   "The sequence of rice chromosomes 11 and 12, rich in disease resistance
RT   genes and recent gene duplications.";
RL   BMC Biol. 3:20-20(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H., McCombie W.R.,
RA   Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S., Childs K.L.,
RA   Davidson R.M., Lin H., Quesada-Ocampo L., Vaillancourt B., Sakai H.,
RA   Lee S.S., Kim J., Numa H., Itoh T., Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using next
RT   generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-157; HIS-276; TYR-379;
RP   HIS-382 AND SER-557.
RX   PubMed=11909851; DOI=10.1074/jbc.m110420200;
RA   Koeduka T., Matsui K., Akakabe Y., Kajiwara T.;
RT   "Catalytic properties of rice alpha-oxygenase. A comparison with mammalian
RT   prostaglandin H synthases.";
RL   J. Biol. Chem. 277:22648-22655(2002).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-311; TYR-379; ARG-558
RP   AND ARG-559.
RX   PubMed=18596034; DOI=10.1074/jbc.m804358200;
RA   Koszelak-Rosenblum M., Krol A.C., Simmons D.M., Goulah C.C., Wroblewski L.,
RA   Malkowski M.G.;
RT   "His-311 and Arg-559 are key residues involved in fatty acid oxygenation in
RT   pathogen-inducible oxygenase.";
RL   J. Biol. Chem. 283:24962-24971(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=21790181; DOI=10.1021/bi201016h;
RA   Huff G.S., Doncheva I.S., Brinkley D.W., Angeles-Boza A.M., Mukherjee A.,
RA   Cramer C.J., Roth J.P.;
RT   "Experimental and computational investigations of oxygen reactivity in a
RT   heme and tyrosyl radical-containing fatty acid alpha-(di)oxygenase.";
RL   Biochemistry 50:7375-7389(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 10-618 IN COMPLEX WITH
RP   HEXADECANOATE; HEME AND CALCIUM ION, AND COFACTOR.
RX   PubMed=23934749; DOI=10.1002/pro.2327;
RA   Zhu G., Koszelak-Rosenblum M., Malkowski M.G.;
RT   "Crystal structures of alpha-dioxygenase from Oryza sativa: insights into
RT   substrate binding and activation by hydrogen peroxide.";
RL   Protein Sci. 22:1432-1438(2013).
CC   -!- FUNCTION: Alpha-dioxygenase that catalyzes the primary oxygenation step
CC       of a variety of 14-20 carbon fatty acids, containing up to three
CC       unsaturated bonds, into their corresponding 2R-hydroperoxides
CC       (PubMed:11909851, PubMed:18596034). Involved in the production of
CC       oxylipins that function in cell signaling, wound healing, and
CC       protection from infection (PubMed:11909851, PubMed:18596034).
CC       {ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-saturated fatty acid + O2 = a (2R)-2-hydroperoxy fatty
CC         acid; Xref=Rhea:RHEA:63508, ChEBI:CHEBI:15379, ChEBI:CHEBI:83955,
CC         ChEBI:CHEBI:147340; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63509;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate + O2 = (2R,9Z,12Z)-2-
CC         hydroperoxyoctadecadienoate; Xref=Rhea:RHEA:63860, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:149618; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63861;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoate + O2 = (2R)-2-hydroperoxyhexadecanoate;
CC         Xref=Rhea:RHEA:63836, ChEBI:CHEBI:7896, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:149616; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63837;
CC         Evidence={ECO:0000269|PubMed:11909851, ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoate + O2 = (R)-2-hydroperoxy-
CC         (9Z,12Z,15Z)-octadecatrienoate; Xref=Rhea:RHEA:16329,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32387, ChEBI:CHEBI:76161;
CC         EC=1.13.11.92; Evidence={ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16330;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + tetradecanoate = (2R)-2-hydroperoxytetradecanoate;
CC         Xref=Rhea:RHEA:63856, ChEBI:CHEBI:15379, ChEBI:CHEBI:30807,
CC         ChEBI:CHEBI:149617; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63857;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + octadecanoate = (2R)-2-hydroperoxyoctadecanoate;
CC         Xref=Rhea:RHEA:63864, ChEBI:CHEBI:15379, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:149622; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63865;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoate + O2 = (2R,9Z)-2-hydroperoxyoctadecenoate;
CC         Xref=Rhea:RHEA:63868, ChEBI:CHEBI:15379, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:149623; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63869;
CC         Evidence={ECO:0000269|PubMed:18596034};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000269|PubMed:23934749};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group per subunit.
CC       {ECO:0000269|PubMed:23934749};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:23934749};
CC       Note=Binds 1 calcium ion per subunit. {ECO:0000269|PubMed:23934749};
CC   -!- SIMILARITY: Belongs to the peroxidase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00298}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF229813; AAF64042.2; -; mRNA.
DR   EMBL; DP000011; ABA98060.2; -; Genomic_DNA.
DR   EMBL; DP000011; ABG22010.1; -; Genomic_DNA.
DR   EMBL; AP014968; BAT17016.1; -; Genomic_DNA.
DR   RefSeq; XP_015620386.1; XM_015764900.1.
DR   PDB; 4KVJ; X-ray; 2.12 A; A=10-618.
DR   PDB; 4KVK; X-ray; 1.98 A; A=10-618.
DR   PDB; 4KVL; X-ray; 1.96 A; A=10-618.
DR   PDBsum; 4KVJ; -.
DR   PDBsum; 4KVK; -.
DR   PDBsum; 4KVL; -.
DR   AlphaFoldDB; Q2QRV3; -.
DR   SMR; Q2QRV3; -.
DR   STRING; 4530.OS12T0448900-01; -.
DR   PeroxiBase; 4159; OsDiOx01.
DR   PaxDb; Q2QRV3; -.
DR   PRIDE; Q2QRV3; -.
DR   EnsemblPlants; Os12t0448900-01; Os12t0448900-01; Os12g0448900.
DR   GeneID; 4352160; -.
DR   Gramene; Os12t0448900-01; Os12t0448900-01; Os12g0448900.
DR   KEGG; osa:4352160; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   HOGENOM; CLU_033051_0_0_1; -.
DR   InParanoid; Q2QRV3; -.
DR   OMA; AFAPWTK; -.
DR   OrthoDB; 276568at2759; -.
DR   BRENDA; 1.13.11.92; 4460.
DR   Proteomes; UP000059680; Chromosome 12.
DR   GO; GO:0012511; C:monolayer-surrounded lipid storage body; IEA:EnsemblPlants.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IBA:GO_Central.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:1902609; P:(R)-2-hydroxy-alpha-linolenic acid biosynthetic process; IEA:EnsemblPlants.
DR   GO; GO:0008219; P:cell death; IEA:EnsemblPlants.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IEA:EnsemblPlants.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IEA:EnsemblPlants.
DR   GO; GO:0071446; P:cellular response to salicylic acid stimulus; IEA:EnsemblPlants.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:EnsemblPlants.
DR   GO; GO:0050832; P:defense response to fungus; IEA:EnsemblPlants.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; IEA:EnsemblPlants.
DR   GO; GO:0031408; P:oxylipin biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009737; P:response to abscisic acid; IEA:EnsemblPlants.
DR   GO; GO:0009627; P:systemic acquired resistance; IEA:EnsemblPlants.
DR   CDD; cd09818; PIOX_like; 1.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR034815; A_dioxygenase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR010255; Haem_peroxidase_sf.
DR   InterPro; IPR037120; Haem_peroxidase_sf_animal.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Dioxygenase; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Heme; Iron; Lipid biosynthesis; Lipid metabolism;
KW   Metal-binding; Oxidoreductase; Oxylipin biosynthesis; Peroxidase;
KW   Plant defense; Reference proteome.
FT   CHAIN           1..618
FT                   /note="Alpha-dioxygenase PIOX"
FT                   /id="PRO_0000455382"
FT   ACT_SITE        157
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         158
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         162
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         210
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         212
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         214
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         216
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         311
FT                   /ligand="hexadecanoate"
FT                   /ligand_id="ChEBI:CHEBI:7896"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         382
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298,
FT                   ECO:0000269|PubMed:23934749"
FT   BINDING         479
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         483
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   BINDING         599
FT                   /ligand="hexadecanoate"
FT                   /ligand_id="ChEBI:CHEBI:7896"
FT                   /evidence="ECO:0000269|PubMed:23934749"
FT   SITE            259
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   MUTAGEN         157
FT                   /note="H->Q: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:11909851"
FT   MUTAGEN         276
FT                   /note="H->Q: Reduces oxygenase activity 3.75-fold."
FT                   /evidence="ECO:0000269|PubMed:11909851"
FT   MUTAGEN         311
FT                   /note="H->A: Reduces oxygenase activity 38-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         311
FT                   /note="H->L: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         311
FT                   /note="H->Q: Reduces oxygenase activity 8.7-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         379
FT                   /note="Y->F: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:11909851,
FT                   ECO:0000269|PubMed:18596034"
FT   MUTAGEN         382
FT                   /note="H->Q: Reduces oxygenase activity 7.5-fold."
FT                   /evidence="ECO:0000269|PubMed:11909851"
FT   MUTAGEN         557
FT                   /note="S->A: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:11909851"
FT   MUTAGEN         558
FT                   /note="R->A: Reduces oxygenase activity 2-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         558
FT                   /note="R->K: Reduces oxygenase activity 5.5-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         558
FT                   /note="R->L: Slightly reduces oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         559
FT                   /note="R->A: Reduces oxygenase activity 250-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         559
FT                   /note="R->E: Reduces oxygenase activity 71-fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         559
FT                   /note="R->K: Reduces oxygenase activity more than 100-
FT                   fold."
FT                   /evidence="ECO:0000269|PubMed:18596034"
FT   MUTAGEN         559
FT                   /note="R->L: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:18596034"
SQ   SEQUENCE   618 AA;  70441 MW;  BA0FD6A808E42A91 CRC64;
     MGSGLFKPRV HPDLRDVFSK MSFFDKIGFL FIHAFDKRNL WHKVPVPIGL LYLNTRRTLL
     EKYNLLAVGR SSHGALFDPK EFLYRTEDGK YNDPHNAEAG SQNTFFGRNM EPVDQQDELM
     SPDPFVVATK LLARREYKDT GKQFNILAAA WIQFMVHDWM DHMEDTGQIG ITAPKEVANE
     CPLKSFKFHP TKELPTNSDG IKIGHYNIRT AWWDGSAVYG NNEERAEKLR TYVDGKLVIG
     DDGLLLHKEN GVALSGDIRN SWAGVSILQA LFVKEHNAVC DAIKEEHPNL SDEELYRYAK
     LVTSAVIAKV HTIDWTVELL KTKTMRAAMR ANWYGLLGKK IKDTFGHIGG PILGGLVGLK
     KPNNHGVPYS LTEEFTSVYR MHSLIPSTLK LRDPTGQPDA NNSPPCLEDI DIGEMIGLKG
     EEQLSKIGFE KQALSMGYQA CGALELWNYP SFFRNLIPQN LDGTNRSDRI DLAALEVYRD
     RERSVPRYNE FRRRLFLIPI KSWEDLTSDK DAIETIRAIY GDDVEKLDLL VGLMAEKKIK
     GFAISETAFN IFILMASRRL EADRFFTSNF NEETYTKKGM QWVKTTEGLR DVINRHYPEI
     TAKWMKSSSA FSVWDADY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024